Cargando…

A Narrative Review of COVID-19 Vaccines

The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since the early days of the pandemic, development of safe and effective vaccines was judged to be the best possible tool to minimize...

Descripción completa

Detalles Bibliográficos
Autores principales: Eroglu, Barbaros, Nuwarda, Rina Fajri, Ramzan, Iqbal, Kayser, Veysel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779282/
https://www.ncbi.nlm.nih.gov/pubmed/35062723
http://dx.doi.org/10.3390/vaccines10010062
_version_ 1784637537212432384
author Eroglu, Barbaros
Nuwarda, Rina Fajri
Ramzan, Iqbal
Kayser, Veysel
author_facet Eroglu, Barbaros
Nuwarda, Rina Fajri
Ramzan, Iqbal
Kayser, Veysel
author_sort Eroglu, Barbaros
collection PubMed
description The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since the early days of the pandemic, development of safe and effective vaccines was judged to be the best possible tool to minimize the effects of this pandemic. Drastic public health measures were put into place to stop the spread of the virus, with the hope that vaccines would be available soon. Thanks to the extraordinary commitments of many organizations and individuals from around the globe and the collaborative effort of many international scientists, vaccines against COVID-19 received regulatory approval for emergency human use in many jurisdictions in less than a year after the identification of the viral sequence. Several of these vaccines have been in use for some time; however, the pandemic is still ongoing and likely to persist for the foreseeable future. This is due to many reasons including reduced compliance with public health restrictions, limited vaccine manufacturing/distribution capacity, high rates of vaccine hesitancy, and the emergence of new variants with the capacity to spread more easily and to evade current vaccines. Here we discuss the discovery and availability of COVID-19 vaccines and evolving issues around mass vaccination programs.
format Online
Article
Text
id pubmed-8779282
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87792822022-01-22 A Narrative Review of COVID-19 Vaccines Eroglu, Barbaros Nuwarda, Rina Fajri Ramzan, Iqbal Kayser, Veysel Vaccines (Basel) Review The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and societal negative impacts at the global scale have been catastrophic. Since the early days of the pandemic, development of safe and effective vaccines was judged to be the best possible tool to minimize the effects of this pandemic. Drastic public health measures were put into place to stop the spread of the virus, with the hope that vaccines would be available soon. Thanks to the extraordinary commitments of many organizations and individuals from around the globe and the collaborative effort of many international scientists, vaccines against COVID-19 received regulatory approval for emergency human use in many jurisdictions in less than a year after the identification of the viral sequence. Several of these vaccines have been in use for some time; however, the pandemic is still ongoing and likely to persist for the foreseeable future. This is due to many reasons including reduced compliance with public health restrictions, limited vaccine manufacturing/distribution capacity, high rates of vaccine hesitancy, and the emergence of new variants with the capacity to spread more easily and to evade current vaccines. Here we discuss the discovery and availability of COVID-19 vaccines and evolving issues around mass vaccination programs. MDPI 2021-12-31 /pmc/articles/PMC8779282/ /pubmed/35062723 http://dx.doi.org/10.3390/vaccines10010062 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Eroglu, Barbaros
Nuwarda, Rina Fajri
Ramzan, Iqbal
Kayser, Veysel
A Narrative Review of COVID-19 Vaccines
title A Narrative Review of COVID-19 Vaccines
title_full A Narrative Review of COVID-19 Vaccines
title_fullStr A Narrative Review of COVID-19 Vaccines
title_full_unstemmed A Narrative Review of COVID-19 Vaccines
title_short A Narrative Review of COVID-19 Vaccines
title_sort narrative review of covid-19 vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779282/
https://www.ncbi.nlm.nih.gov/pubmed/35062723
http://dx.doi.org/10.3390/vaccines10010062
work_keys_str_mv AT eroglubarbaros anarrativereviewofcovid19vaccines
AT nuwardarinafajri anarrativereviewofcovid19vaccines
AT ramzaniqbal anarrativereviewofcovid19vaccines
AT kayserveysel anarrativereviewofcovid19vaccines
AT eroglubarbaros narrativereviewofcovid19vaccines
AT nuwardarinafajri narrativereviewofcovid19vaccines
AT ramzaniqbal narrativereviewofcovid19vaccines
AT kayserveysel narrativereviewofcovid19vaccines